Literature DB >> 6743483

Pharmacokinetics of cyclophosphamide in Kenyan African children with lymphoma.

F D Juma, D K Koech, E G Kasili, T Ogada.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6743483      PMCID: PMC1463578          DOI: 10.1111/j.1365-2125.1984.tb05032.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  7 in total

Review 1.  Clinical pharmacokinetics of cyclophosphamide.

Authors:  L B Grochow; M Colvin
Journal:  Clin Pharmacokinet       Date:  1979 Sep-Oct       Impact factor: 6.447

2.  Clinical pharmacology of cyclophosphamide.

Authors:  C M Bagley; F W Bostick; V T DeVita
Journal:  Cancer Res       Date:  1973-02       Impact factor: 12.701

3.  Pharmacokinetics of cyclophosphamide in Kenyan Africans.

Authors:  F Juma; T Ogada
Journal:  Br J Clin Pharmacol       Date:  1983-07       Impact factor: 4.335

4.  Some aspects of the gas--liquid chromatographic analysis of cyclophosphamide in plasma.

Authors:  N van den Bosch; D de Vos
Journal:  J Chromatogr       Date:  1980-07-11

5.  Pharmacokinetics of cyclophosphamide and alkylating activity in man after intravenous and oral administration.

Authors:  F D Juma; H J Rogers; J R Trounce
Journal:  Br J Clin Pharmacol       Date:  1979-09       Impact factor: 4.335

6.  PLasma half-life and urinary excretion of cyclophosphamide in children.

Authors:  N E Sladek; J Priest; D Doeden; C J Mirocha; S Pathre; W Krivit
Journal:  Cancer Treat Rep       Date:  1980 Oct-Nov

7.  Pharmacokinetics of intravenous cyclophosphamide in man, estimated by gas-liquid chromatography.

Authors:  F D Juma; H J Rogers; J R Trounce; I D Bradbrook
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

  7 in total
  2 in total

1.  Pharmacokinetics and metabolism of cyclophosphamide in paediatric patients.

Authors:  M J Tasso; A V Boddy; L Price; R A Wyllie; A D Pearson; J R Idle
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 2.  Clinical pharmacokinetics of cyclophosphamide.

Authors:  Milly E de Jonge; Alwin D R Huitema; Sjoerd Rodenhuis; Jos H Beijnen
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 5.577

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.